FALLOPIAN TUBE ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: FALLOPIAN TUBE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New drug combo could slow ovarian Cancer's return
Disease control OngoingThis study tests whether adding the immunotherapy drug oregovomab to standard chemotherapy can help people with advanced ovarian cancer live longer without their cancer growing. About 615 newly diagnosed patients who had surgery to remove most of their cancer will receive either …
Matched conditions: FALLOPIAN TUBE ADENOCARCINOMA
Phase: PHASE3 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC